Implantation of a Tissue-engineered Heart Valve from Human Fibroblasts Exhibiting Short Term Function in the Sheep Pulmonary Artery

Cardiovascular Engineering and Technology

Volumn 2, Issue 2, 2011, Pages 101-112

  Syedain, Zeeshan H ^a   Lahti, Matthew T ^b   Johnson, Sandra L ^a   Robinson, Paul S ^a   Ruth, George R ^b   Bianco, Richard W ^b,c   Tranquillo, Robert T ^a  

^a University of Minnesota   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Fibrin; Fibroblast; Heart valve; Ovine; Tissue engineering

Indexed keywords

CYCLIC STRETCHING; ENDOTHELIALIZATION; FIBRIN; HEART VALVE; HOST CELLS; HUMAN DERMAL FIBROBLASTS; HUMAN FIBROBLAST; IMMUNOCYTOCHEMISTRY; MECHANICAL ANISOTROPY; ORIFICE AREA; OVINE; PILOT STUDIES; PULMONARY ARTERY; SHEEP MODEL; SHORT TERM; TISSUE-ENGINEERED HEART;

CELL CULTURE; ECHOCARDIOGRAPHY; FIBROBLASTS; HEART; TISSUE; TURBULENCE; WASTE DISPOSAL; WOOL;

VALVES (MECHANICAL);

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CELL VIABILITY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART VALVE REPLACEMENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; NEWBORN; NONHUMAN; PRESSURE GRADIENT; PULMONARY ARTERY; SHEEP; SKIN FIBROBLAST; STRUCTURE ANALYSIS; TENSILE STRENGTH; TISSUE ENGINEERING;

EID: 79955864203     PISSN: 1869408X     EISSN: 18694098     Source Type: Journal    
DOI: 10.1007/s13239-011-0039-5     Document Type: Article

References (28)

1. Allen, H. D., D. J. Driscoll, R. E. Shaddy, and T. F. Feltes. Moss and Adams' Heart Disease in Infants, Children, and Adolescents. Philadelphia: Lippincott Williams & Wilkins, 2008.
2. Flanagan, T. C., J. S. Sachweh, J. Frese, H. Schnoring, N. Gronloh, S. Koch, et al. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng. 15: 2965-2976, 2009.
3. Gallegos, R. P., P. J. Nockel, A. L. Rivard, and R. W. Bianco. The current state of in vivo pre-clinical animal models for heart valve evaluation. J. Heart Valve Dis. 14: 423-432, 2005.
4. Gong, X. J., X. Q. Zhang, Y. Song, Y. H. Li, X. Y. Pang, and S. X. Li. Effects of immunosuppressive treatment in prevention of calcification in aortic valved homograft: experiment with rats. Zhonghua yi xue za zhi 87: 2132-2135, 2007.
5. Gottlieb, D., T. Kunal, S. Emani, E. Aikawa, D. W. Brown, A. J. Powell, et al. In vivo monitoring of function of autologous engineered pulmonary valve. J. Thorac. Cardiovas. Surg. 139: 723-731, 2010.
6. Grassl, E. D., T. R. Oegema, and R. T. Tranquillo. Fibrin as an alternative biopolymer to type I collagen for fabrication of a media-equivalent. J. Biomed. Mater. Res. 60: 607-612, 2002.
7. Grinnell, F., and C. H. Ho. Transforming growth factor beta stimulates fibroblast-collagen matrix contraction by different mechanisms in mechanically loaded and unloaded matrices. Exp. Cell Res. 273: 248-255, 2002.
8. Hoerstrup, S. P., R. Sodian, S. Daebritz, J. Wang, E. A. Bacha, D. P. Martin, et al. Functional living trileaflet heart valves grown in vitro. Circulation 102: III44-III49, 2000.
9. Jockenhoevel, S., K. Chalabi, J. S. Sachweh, H. V. Groesdonk, L. Demircan, M. Grossmann, et al. Tissue engineering: complete autologous valve conduit-a new moulding technique. Thorac. Cardiovasc. Surg. 49: 287-290, 2001.
10. Kim, B. S., and D. J. Mooney. Engineering smooth muscle tissue with a predefined structure. J. Biomed. Mater. Res. 41: 322-332, 1998.
11. L'Heureux, N., N. Dusserre, G. Konig, B. Victor, P. Keire, T. N. Wight, et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat. Med. 12: 361-365, 2006.
12. L'Heureux, N., T. N. McAllister, and L. M. de la Fuente. Tissue-engineered blood vessel for adult arterial revascularization. N. Engl. J. Med. 357: 1451-1453, 2007.
13. Long, J. L., and R. T. Tranquillo. Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol. 22: 339-350, 2003.
14. McAllister, T. N., M. Maruszewski, S. A. Garrido, W. Wystrychowski, N. Dusserre, A. Marini, et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 373: 1440-1446, 2009.
15. Mol, A., M. C. Rutten, N. J. Driessen, C. V. Bouten, G. Zund, F. P. Baaijens, et al. Autologous human tissue-engineered heart valves: prospects for systemic application. Circulation 114: I152-I158, 2006.
16. Mrugala, D., C. Bony, N. Neves, L. Caillot, S. Fabre, D. Moukoko, et al. Phenotypic and functional characterisation of ovine mesenchymal stem cells: application to a cartilage defect model. Ann. Rheum. Dis. 67: 288-295, 2008.
17. Robinson, P. S., and R. T. Tranquillo. Planar biaxial behavior of fibrin-based tissue-engineered heart valve leaflets. Tissue Eng. 15: 2763-2772, 2009.
18. Robinson, P. S., S. L. Johnson, M. C. Evans, V. H. Barocas, and R. T. Tranquillo. Functional tissue-engineered valves from cell-remodeled fibrin with commissural alignment of cell-produced collagen. Tissue Eng. Part A 14: 83-95, 2008.
19. Rosamond, W., K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117: e25-e146, 2008.
20. Sabet, H. Y., W. D. Edwards, H. D. Tazelaar, and R. C. Daly. Congenitally bicuspid aortic valves: a surgical pathology study of 542 cases (1991 through 1996) and a literature review of 2, 715 additional cases. Mayo Clin. Proc. 74: 14-26, 1999.
21. Schmidt, D., P. E. Dijkman, A. Driessen-Mol, R. Stenger, C. Mariani, A. Puolakka, et al. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J. Am. Coll. Cardiol. 56: 510-520, 2010.
22. Sodian, R., S. P. Hoerstrup, J. S. Sperling, S. Daebritz, D. P. Martin, A. M. Moran, et al. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation 102: III22-III29, 2000.
23. Sodian, R., S. P. Hoerstrup, J. S. Sperling, S. H. Daebritz, D. P. Martin, F. J. Schoen, et al. Tissue engineering of heart valves: in vitro experiences. Ann. Thorac. Surg. 70: 140-144, 2000.
24. Stegemann, H., and K. Stalder. Determination of hydroxyproline. Clin. Chim. Acta Int. J. Clin. Chem. 18: 267-273, 1967.
25. Sung, H. J., C. Meredith, C. Johnson, and Z. S. Galis. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials 25: 5735-5742, 2004.
26. Sutherland, F. W., T. E. Perry, Y. Yu, M. C. Sherwood, E. Rabkin, Y. Masuda, et al. From stem cells to viable autologous semilunar heart valve. Circulation 111: 2783-2791, 2005.
27. Syedain, Z. H., and R. T. Tranquillo. Controlled cyclic stretch bioreactor for tissue-engineered heart valves. Biomaterials 30: 4078-4084, 2009.
28. Syedain, Z. H., J. S. Weinberg, and R. T. Tranquillo. Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue. Proc. Natl Acad. Sci. U. S. A. 105: 6537-6542, 2008.